Full Name

Email

Phone

I have read and agree to the Terms and Conditions I declare that I am over 18 years of age, I have read, understood and accept the Terms and Conditions - Client Agreement
By submitting my personal details, I consent to be contacted by Xtrade, by any communication means provided. For Xtrade’s Privacy Policy, please click here.
I declare that the provided information is true, correct, complete and submitted voluntarily. I undertake the obligation to inform immediately Xtrade in writing in case of any change to that information and to provide any other data or documents, if necessary. I have read and agree to the Terms and Conditions I understand that residents of my country are not be eligible to apply for an account with this XTRADE.com offering, but I would like to continue.

GlaxoSmithKline

SHARES

1318.75

n/a%

High: 1315.50

Low: 1302.00

1302.75

Sell

1318.75

Buy

Spread Per Unit	900-1600	Spread (%)	1.23
Premium Buy	-110	Premium Sell	-100
Maintenance Margin	2.50%	Expiry Date	n/a
Leverage	10	Trading Hours

Trade over 1,000 international shares with Xtrade's CFD trading platform.

Start trading CFDs in GlaxoSmithKline. Get real-time quotes and receive dividends as if you held the share itself.

Trading CFDs involves significant risk of loss. Trading FX/CFDs involves a significant level of risk and you may lose all of your invested capital. Please ensure that you understand the risks involved.

Thank you for visiting xtrade.com

You are currently viewing our global website which is not directed at EU residents.
Please let us know how you would like to proceed.

GlaxoSmithKline

SHARES

Sell

Buy

or

or

Receive your login details to your email address

Thank you for visiting xtrade.com

You are currently viewing our global website which is not directed at EU residents. Please let us know how you would like to proceed.

GlaxoSmithKline

SHARES

Sell

Buy

You are currently viewing our global website which is not directed at EU residents.
Please let us know how you would like to proceed.